Utility of C-11-methionine PET in a clinical trial of Glivec and hydroxyurea in recurrent glioblastoma (GBM). [Society of Nuclear Medicine (SNM) 56th Annual Meeting, Toronto, Canada]

K Herholz, D Coope, A Weir, H Rupani, Z. Nikolova

    Research output: Contribution to journalCommentary/debatepeer-review

    Original languageEnglish
    Pages (from-to)192
    JournalJournal Of Nuclear Medicine
    Volume50 (suppl 2)
    Publication statusPublished - 2009

    Keywords

    • PET
    • GBM

    Cite this